Kindred Biosciences Inc (KIN)

4.16
0.22 5.02
NASDAQ : Health Care
Prev Close 4.38
Open 4.35
Day Low/High 4.11 / 4.35
52 Wk Low/High 2.90 / 6.38
Volume 46.36K
Avg Volume 24.90K
Exchange NASDAQ
Shares Outstanding 19.89M
Market Cap 85.93M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Kindred Biosciences To Announce Second Quarter 2016 Financial Results

Kindred Biosciences To Announce Second Quarter 2016 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Monday, August 8, 2016

Value Portfolio Performs Well Amid Brexit Turmoil

A group of seven to 15 securities, if carefully selected, can provide all the diversification an investor needs.

It's Patient Capital's Time to Prosper

Brexit has caused active investors to flee and created an opportunity for those who are patient.

Kindred Biosciences Announces Positive Results From Pivotal Study Of KIND-010 For The Management Of Weight Loss In Cats

Kindred Biosciences Announces Positive Results From Pivotal Study Of KIND-010 For The Management Of Weight Loss In Cats

Conference call and webcast scheduled for 4:30 p.m. ET / 1:30 p.m. PT today

Portfolio Patience Is a Virtue

The energy rally is a good example.

Kindred Biosciences To Announce First Quarter 2016 Financial Results

Kindred Biosciences To Announce First Quarter 2016 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Thursday, May 5, 2016

Two Little Gems Are Hidden Amid Small-Caps

Sometimes, the under-research companies offer the biggest opportunities.

Kindred Biosciences Elects Herbert D. Montgomery To Join Its Board Of Directors

Kindred Biosciences Elects Herbert D. Montgomery To Join Its Board Of Directors

Highly Experienced Finance Executive to Join KindredBio's Board

Kindred Biosciences To Announce Fourth Quarter And Year-End 2015 Financial Results

Kindred Biosciences To Announce Fourth Quarter And Year-End 2015 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Wednesday, March 2, 2016

Kindred Biosciences Announces Positive Results From Pivotal Study Of KIND-012 For Pyrexia In Horses, And Provides Other Product Updates

Kindred Biosciences Announces Positive Results From Pivotal Study Of KIND-012 For Pyrexia In Horses, And Provides Other Product Updates

KIND-012 study meets primary endpoint with p<0.0001. Data to be filed with the FDA for approval. SentiKind study misses primary endpoint.

Relative Strength Alert For Kindred Biosciences

Relative Strength Alert For Kindred Biosciences

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Relative Strength Alert For Kindred Biosciences

Relative Strength Alert For Kindred Biosciences

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Kindred Biosciences Announces Positive Results Of Pilot Field Study Of KIND-012 For The Control Of Fever In Horses

Kindred Biosciences Announces Positive Results Of Pilot Field Study Of KIND-012 For The Control Of Fever In Horses

Randomized, Blinded, Placebo-Controlled Phase 2 Study Meets Its Primary Endpoint.

KindredBio To Announce Fourth Quarter And Year-End 2014 Financial Results

KindredBio To Announce Fourth Quarter And Year-End 2014 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time on Thursday, March 12, 2015

Oversold Conditions For Kindred Biosciences (KIN)

Oversold Conditions For Kindred Biosciences (KIN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Kindred Bio To Announce Third Quarter 2014 Financial Results

Kindred Bio To Announce Third Quarter 2014 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time on Thursday, November 13, 2014